LIDDS.ST Gross Margin

The Gross Margin of Lidds AB (LIDDS.ST) is -1102.81%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

LIDDS.ST Gross Margin - Historical Value

Date	Value
2024-12-31	-1102.81%
2023-12-31	-1102.81%
2022-12-31	-745.92%

LIDDS.ST Gross Margin - Peers Comparison

Ticker	Name	Value
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
BONEX.ST	Bonesupport Holding AB	92.60%
IVACC.ST	Intervacc AB	-29.92%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
GNRO.PA	Geneuro SA	7775.20%
KURN.SW	Kuros Biosciences AG	109.30%
SENZA.ST	SenzaGen AB	66.89%
VAL.L	ValiRx PLC	85.00%
ALPRE.PA	Predilife SA	97.25%
ATORX.ST	Alligator Bioscience AB	-312.94%
TRVX.OL	Targovax ASA	7775.20%
AEGIR.ST	Aegirbio AB	47.83%
MTPH.L	Midatech Pharma PLC	94.91%
PROB.ST	Probi AB	35.08%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	78.03%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
RENE.L	ReNeuron Group PLC	100.00%
SCS.WA	Stem Cells Spin SA	86.16%
T5O.DE	bioXXmed AG	100.00%
XBRANE.ST	Xbrane Biopharma AB	90.83%
ACTI.ST	Active Biotech AB publ	100.00%
EVG.L	Evgen Pharma PLC	-1151.58%
HNSA.ST	Hansa Biopharma AB	51.23%
PROMO.ST	Promore Pharma AB	-124472.22%
SPRINT.ST	Sprint Bioscience AB	56.83%
VITR.ST	Vitrolife AB	59.27%
BIOA B.ST	BioArctic AB	89.51%
ALNEV.PA	Neovacs SA	5.49%
MVIR B.ST	Medivir AB	-147045.00%
ADOC.PA	Adocia SA	64.42%
ALHYG.PA	Hybrigenics SA	99.47%
BIOG B.ST	Biogaia AB	72.45%
GV.PA	Genomic Vision SA	-165.01%
PUR.WA	Pure Biologics SA	-2709.47%
XINT.ST	Xintela AB	100.00%
ABNX.PA	Abionyx Pharma SA	18.35%